Position in CADL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$17,546
-$6,359 QoQ
Shares Held
3,581
-15.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. CADL ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in CADL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,546 | 3,581 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $23,905 | 4,231 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,578 | 4,231 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $22,198 | 4,387 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $17,509 | 3,099 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,069 | 2,197 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,225 | 2,197 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $13,621 | 2,197 | Shares | Defined | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||